Tripp Peake

Tripp Peake is a venture investor and company builder with a proven track record in healthcare and technology. He co-founded LRVHealth in 2000 and has led the firm’s investments in Diameter Health, Extreme Reach, First Light Diagnostics, Optasite (acquired by SBA), Protedyne (acquired by LabCorp), Socially Determined, and Verata. He was previously a partner at Kestrel Ventures (a Boston-based early-stage venture firm), founding CEO of Mass Ventures (a UMass-affiliated seed fund), and co-founder/CEO of Science Park Associates (a venture development company affiliated with Yale University, Yale Medical School, and Yale New Haven Hospital). Tripp earned a B.A. from Dartmouth College and M.B.A. from Yale University.